Transcription Factors

We are comprehensively preparing a series of high-quality monoclonal antibodies against transcription factors and nuclear proteins in order to supply research tools for transcriptional regulation studies. Our innovative technology will enable study of protein complex and ChIP on chip analysis.

We offers a variety of antibodies that are exhaustively produced by using "Concomitant Immunization with Multiple Antigens", which is BMR's proprietary method of producing monoclonal antibodies. We are currently producing monoclonal antibodies that target mainly DNA binding proteins in the nucleus.